Future Health ESG Corp. financial data

Industry
Blank Checks
Location
8 The Green, Suite # 12081, Dover, DE
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-K - Q4 2023 - Mar 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13 % -89.6%
Debt-to-equity -122 % -6.87%
Return On Equity 0.49 %
Return On Assets -0.28 % -836%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.94M shares -9.94%
Common Stock, Shares, Outstanding 5M shares 0%
Entity Public Float 16.4M USD -93.4%
Common Stock, Value, Issued 500 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 628K USD -71.6%
Operating Income (Loss) -679K USD +71.8%
Nonoperating Income (Expense) 215K USD -76.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 106K USD -48.4%
Income Tax Expense (Benefit) 154K USD
Net Income (Loss) Attributable to Parent -48.4K USD -181%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120K USD -85.7%
Marketable Securities, Current 17.1M USD +4.72%
Assets, Current 127K USD -86.3%
Other Assets, Noncurrent 27K USD
Assets 17.2M USD -0.17%
Accounts Payable, Current 917K USD +1461%
Accrued Liabilities, Current 15.5K USD -69.1%
Liabilities, Current 8.44M USD +542%
Liabilities 17.4M USD +69.1%
Retained Earnings (Accumulated Deficit) -10.3M USD -9.47%
Stockholders' Equity Attributable to Parent -10.3M USD -9.47%
Liabilities and Equity 17.2M USD -0.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -158K USD +50.1%
Common Stock, Shares Authorized 26M shares -94.8%
Common Stock, Shares, Issued 5M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -158K USD +50.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120K USD -85.7%
Deferred Tax Assets, Valuation Allowance 270K USD +93.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 270K USD +93.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%